What are the appropriate needle gauge and length for intramuscular injections in adults (including obese adults), children (10–30 kg and 30–50 kg), and infants (<10 kg) for deltoid and gluteal sites?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 1, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Intramuscular Injection Needle Size Recommendations

For intramuscular injections in adults, use a 1-inch (25 mm) needle for the deltoid site in most patients, with a 1.5-inch (38 mm) needle reserved for obese adults (women >90 kg, men >118 kg); for children, use 7/8 to 1 inch for infants <12 months in the anterolateral thigh, and 7/8 to 1.25 inches for the deltoid in children with adequate muscle mass. 1, 2

Adults - Deltoid Site

Standard Adults

  • Needle length: 1 inch (25 mm) for most adults
  • Gauge: 22-25 gauge (standard for IM injections)
  • Men weighing 59-118 kg: 1-inch needle ensures adequate muscle penetration 3
  • Women <60 kg: 1-inch needle is sufficient 3
  • Women 60-90 kg: 1-inch needle is appropriate 3

Obese Adults

The evidence clearly demonstrates that standard needles fail to reach muscle in obese patients:

  • Women >90 kg: 1.5-inch (38 mm) needle required 3
  • Men >118 kg: 1.5-inch needle recommended 4
  • Practical screening thresholds:
    • Men with arm circumference >35 cm: use longer needle 5
    • Women with arm circumference >30 cm: use longer needle 5
    • Women with BMI >31.6 kg/m²: use longer needle 5
    • Men with BMI >38.2 kg/m²: use longer needle 5

Critical pitfall: Standard 1-inch needles fail to reach muscle in 48% of women and 17% of men in the general adult population 3. In obese patients (BMI >25), 98% of women and 37% of men at the dorsogluteal site would not reach muscle with standard needles 6.

Optimal Injection Site

Inject 4 cm distal to the posterolateral corner of the acromion - this is more posterior and inferior than traditional teaching, maximizing successful IM delivery while minimizing overpenetration and axillary nerve injury risk 4.

Children and Adolescents

Infants (<12 months)

  • Site: Anterolateral thigh (preferred)
  • Needle length: 7/8 to 1 inch (22-25 mm) 1, 2
  • Gauge: 22-25 gauge
  • Insert at 90-degree angle

Young Children (1-2 years, typically <10 kg)

  • Site: Anterolateral thigh (preferred)
  • Needle length: 7/8 to 1 inch 1
  • Gauge: 22-25 gauge

Children 10-30 kg

  • Deltoid site (if adequate muscle mass):
    • Needle length: 7/8 to 1.25 inches (22-32 mm) 1
    • Gauge: 22-25 gauge
  • Thigh site: 7/8 to 1 inch

Children 30-50 kg and Early Adolescents

  • Weight <60 kg: 5/8-inch (16 mm) needle is acceptable in 88-98% using bunch technique 7
  • Weight ≥60 kg: 1-inch (25 mm) needle is acceptable in 100% 7
  • Gauge: 22-25 gauge

The bunch technique (pinching deltoid muscle) allows for shorter needles compared to the flatten technique 7.

Gluteal Sites (All Ages)

Important caveat: The gluteal site is problematic in obese patients. At the dorsogluteal site, mean subcutaneous tissue thickness is:

  • Overweight adults: 34.5 mm
  • Obese adults: 40.2 mm
  • Extremely obese adults: 51.4 mm 6

Standard 1.5-inch needles would fail to reach muscle in 98% of overweight/obese women and 37% of men at the dorsogluteal site 6. The ventrogluteal site has similar limitations (97% of women, 57% of men) 6.

Recommendation: Avoid gluteal sites in obese patients or use needles >1.5 inches if this site must be used.

Key Technical Points

Injection Angle

  • Always insert at 90 degrees to the skin surface for all IM injections
  • Do not angle the needle

Gauge Selection

  • 22-25 gauge is standard for IM injections
  • Thinner gauges (higher numbers) cause less pain but may be more difficult for viscous medications
  • 22-23 gauge for viscous medications
  • 25 gauge for less viscous medications and when minimizing pain is priority

Critical Safety Considerations

  1. Measure before injecting: Use arm circumference or BMI as practical screening tools to select appropriate needle length 5

  2. Site selection matters: The posterolateral approach 4 cm distal to the acromion minimizes overpenetration risk while ensuring muscle delivery 4

  3. Avoid overpenetration: Using 1.5-inch needles in patients <118 kg (men) or <90 kg (women) carries high risk of overpenetration through the deltoid muscle 4

  4. Never split doses: A 0.5 mL prefilled syringe should never be divided into two 0.25 mL doses 8

Note: The provided evidence about insulin injection technique [9-9] addresses subcutaneous (not intramuscular) injections and is not applicable to this question about IM injections.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.